Critical role of the virus-encoded microRNA-155 ortholog in the induction of marek's disease lymphomas

PLoS Pathogens

Volumn 7, Issue 2, 2011, Pages

  Zhao, Yuguang ^a   Xu, Hongtao ^b   Yao, Yongxiu ^b   Smith, Lorraine P ^b   Kgosana, Lydia ^b   Green, James ^b   Petherbridge, Lawrence ^b   Baigent, Susan J ^b   Nair, Venugopal ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 4; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; DISEASE ASSOCIATION; GENE DELETION; GENE MUTATION; IN VIVO STUDY; MARDIVIRUS; MAREK DISEASE; NONHUMAN; PHENOTYPE; VIRAL GENETICS; VIRUS ATTENUATION; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; CELL CULTURE; CHICK EMBRYO; CHICKEN; CYTOLOGY; FIBROBLAST; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LYMPHOMA; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; VACCINATION; VIRUS GENOME;

GALLUS GALLUS; HUMAN HERPESVIRUS 8;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; FIBROBLASTS; GENOME, VIRAL; HERPESVIRUS 2, GALLID; HUMANS; LYMPHOMA; MAREK DISEASE; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTATION; RNA, VIRAL; VACCINATION;

EID: 79952224195     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001305     Document Type: Article

References (46)

1. Javier RT, Butel JS, (2008) The history of tumor virology. Cancer Res 68: 7693-7706.
2. Croce CM, (2008) Oncogenes and cancer. N Engl J Med 358: 502-511.
3. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
4. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
5. Qin Z, Kearney P, Plaisance K, Parsons CH, (2010) Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol 87: 25-34.
6. Lei X, Bai Z, Ye F, Xie J, Kim CG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193-199.
7. Cullen BR, (2009) Viral and cellular messenger RNA targets of viral microRNAs. Nature 457: 421-425.
8. Schat KA, Nair V, (2008) Marek's Disease. In: Saif YM, Fadly AM, Glisson JR, McDougald LR, Nolan LK, editors. Diseases of Poultry. 12 ed Iowa Blackwell Publishing pp. 452-514.
9. Calnek BW, (1986) Marek's disease: a model for herpesvirus oncology. CRC Crit Rev Microbiol 12: 293-320.
10. Lupiani B, Lee LF, Cui X, Gimeno I, Anderson A, et al. (2004) Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101: 11815-11820.
11. Brown AC, Baigent SJ, Smith LP, Chattoo JP, Petherbridge LJ, et al. (2006) Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc Natl Acad Sci U S A 103: 1687-1692.
12. Zhao Y, Kurian D, Xu H, Petherbridge L, Smith LP, et al. (2009) Interaction of Marek's disease virus oncoprotein Meq with heat-shock protein 70 in lymphoid tumour cells. J Gen Virol 90: 2201-2208.
13. Lupiani B, Lee LF, Cui X, Gimeno I, Anderson A, et al. (2004) Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101: 11815-11820.
14. Suchodolski PF, Izumiya Y, Lupiani B, Ajithdoss DK, Gilad O, et al. (2009) Homodimerization of Marek's disease virus-encoded Meq protein is not sufficient for transformation of lymphocytes in chickens. J Virol 83: 859-869.
15. Brown AC, Smith LP, Kgosana L, Baigent SJ, Nair V, et al. (2009) Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus. J Virol 83: 11142-11151.
16. Yao Y, Zhao Y, Xu H, Smith LP, Lawrie CH, et al. (2008) MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J Virol 82: 4007-4015.
17. Morgan R, Anderson A, Bernberg E, Kamboj S, Huang E, et al. (2008) Sequence conservation and differential expression of Marek's disease virus microRNAs. J Virol 82: 12213-12220.
18. Yao Y, Zhao Y, Smith LP, Lawrie CH, Saunders NJ, et al. (2009) Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J Gen Virol 90: 1551-1559.
19. Zhao Y, Yao Y, Xu H, Lambeth L, Smith LP, et al. (2009) A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J Virol 83: 489-492.
20. McClure LV, Sullivan CS, (2008) Kaposi's sarcoma herpes virus taps into a host microRNA regulatory network. Cell Host Microbe 3: 1-3.
21. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, et al. (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature 450: 1096-1099.
22. Muylkens B, Coupeau D, Dambrine G, Trapp S, Rasschaert D, (2010) Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Arch Virol 155: 1823-1837.
23. Tili E, Croce CM, Michaille JJ, (2009) miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 28: 264-284.
24. Faraoni I, Antonetti FR, Cardone J, Bonmassar E, (2009) miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792: 497-505.
25. Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC, (2010) Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci U S A 107: 3111-3116.
26. Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, et al. (2010) Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A 107: 6982-6987.
27. Tischer BK, von Einem J, Kaufer B, Osterrieder N, (2006) Two-step Red-mediated recombination for versatile, high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40: 1-6.
28. Lalioti M, Heath J, (2001) A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli. Nucleic Acids Res 29: E14.
29. Petherbridge L, Brown AC, Baigent SJ, Howes K, Sacco MA, et al. (2004) Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol 78: 13376-13380.
30. Zhao Y, Petherbridge L, Smith LP, Baigent S, Nair V, (2008) Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity. Virol J 5: 19.
31. Xu H, Yao Y, Zhao Y, Smith LP, Baigent SJ, et al. (2008) Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR. J Virol Methods 149: 201-208.
32. Tam W, Hughes SH, Hayward WS, Besmer P, (2002) Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol 76: 4275-4286.
33. Petherbridge L, Howes K, Baigent SJ, Sacco MA, Evans S, et al. (2003) Replication-competent bacterial artificial chromosomes of Marek's disease virus: Novel tools for generation of molecularly defined herpesvirus vaccines. J Virol pp. 8712-8718.
34. Gottwein E, Cullen BR, (2008) Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3: 375-387.
35. Xu S, Xue C, Li J, Bi Y, Cao Y, (2011) Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J Virol 85: 276-285.
36. Faraoni I, Antonetti R, Cardone J, Bonmassar E, (2009) miR-155 gene: A typical multifunctional microRNA. Biochim Biophys Acta 1792: 497-505.
37. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, et al. (2008) Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 82: 10436-10443.
38. Bolisetty MT, Dy G, Tam W, Beemon KL, (2009) Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol 83: 12009-12017.
39. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, et al. (2007) Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81: 12836-12845.
40. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR, (2010) Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 84: 11670-11678.
41. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, et al. (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56-65.
42. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG, (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33: e36.
43. Prentki P, Krisch HM, (1984) In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29: 303-313.
44. Yu D, Ellis HM, Lee EC, Jenkins NA, Copeland NG, et al. (2000) An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci U S A 97: 5978-5983.
45. Zhao Y, Nair V, (2010) Mutagenesis of the repeat regions of herpesviruses cloned as bacterial artificial chromosomes. Methods Mol Biol 634: 53-74.
46. Tahiri-Alaoui A, Matsuda D, Xu H, Panagiotis P, Burman L, et al. (2009) The 5′ leader of the mRNA encoding the marek's disease virus serotype 1 pp14 protein contains an intronic internal ribosome entry site with allosteric properties. J Virol 83: 12769-12778.